Ezzeldin Muktar Abdurahman
Ezzeldin Muktar Abdurahman is a renowned pharmacologist and medical researcher known for his significant contributions to the field of pharmacology. His research primarily focuses on the development of new drugs and the improvement of existing ones, with a particular emphasis on cancer treatment.
Early Life and Education[edit | edit source]
Ezzeldin Muktar Abdurahman was born and raised in Sudan. He pursued his undergraduate studies in Pharmacy at the University of Khartoum, where he developed a keen interest in pharmacology. He then moved to the United States for his postgraduate studies, earning a PhD in Pharmacology from the University of California, San Francisco.
Career[edit | edit source]
Abdurahman has held various positions in academia and the pharmaceutical industry. He has worked as a professor at several prestigious universities, teaching courses on pharmacology and conducting research. In the pharmaceutical industry, he has been involved in the development of several groundbreaking drugs, particularly in the field of oncology.
Research[edit | edit source]
Abdurahman's research has been instrumental in the development of new drugs and therapies for cancer treatment. His work has led to significant advancements in the understanding of how drugs interact with the body and how they can be modified to improve their effectiveness and reduce side effects.
Awards and Recognition[edit | edit source]
Abdurahman's contributions to pharmacology have earned him numerous awards and recognition. He is a member of several professional organizations, including the American Society for Pharmacology and Experimental Therapeutics.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
- [Official Website]
- [Google Scholar Profile]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD